Genomics Creates Strong Market Niche for One Health System

February 8, 2018

Geisinger logoGeisinger Health System is on the cutting edge when it comes to precision medicine, and its capacity in this area has proven to be a strong market differentiator.

As an integrated community health system serving areas of Pennsylvania and New Jersey, Geisinger has long been known for its patient-centered focus and innovative approach to caring for its target audience. Therefore, when the opportunity to branch into the field of genomics arose a decade ago, the system was well positioned to branch out into this area.

In the process, Geisinger has created a unique model that others may replicate in the future and that may be widely scalable. At the same time, it also has provided local patients and their families with more insight into the role their DNA plays in their health status, and offers them the opportunity to make potentially life-saving decisions as needed.

This path into translational research really began about a decade ago, putting Geisinger ahead of the curve in this area.

W. Andrew (Andy) Faucett, professor and director of policy and education in the office of the chief scientific officer at Geisinger

W. Andrew (Andy) Faucett, professor and director of policy and education in the office of the chief scientific officer at Geisinger

“In 2007, Geisinger realized we were the perfect place to carry out community-based genetics research,” explains W. Andrew (Andy) Faucett, professor and director of policy and education in the office of the chief scientific officer at Geisinger.

He points out that an extensive medical records system was a big part of Geisinger’s strength. “We were early adopters of electronic health records (EHR),” he says, adding that this gave Geisinger a framework to gather genomic research and use it meaningfully. “This prompted us to start a precision medicine research project called MyCode Community Health Initiative to get a better understanding of how genomics influences health,” he says.

For all of the details, read our new story now:
Geisinger’s Translational Research Program Provides a Strong Market Differentiator

Best regards,
Matt Humphrey
President

Start Your Online Access Today

Not a member yet?
Sign up for a FREE trial membership »

And don't forget: Once you've signed up as a member, you can add up to 9 colleagues for no additional charge with our Group Membership Upgrade. It's an incredible value.